Georgian Technology News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Georgian Technology News.

Press releases published on October 28, 2026

Oct. 28, 2026

ODDITY to Announce Third Quarter 2026 Financial Results on November 11, 2026

Indeterminate GlobeNewswire

Oct. 28, 2026

RedCloud Announces Issuance of Shares to Insiders in Private Placement at Price per Share of $0.25 for Aggregate Subscription Price of $7.9 million

Indeterminate GlobeNewswire

Oct. 28, 2026

Pyxis Oncology to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Oct. 28, 2026

OptimizeRx Sets Third Quarter 2026 Conference Call for November 11, 2026 at 4:30 p.m. ET

Indeterminate GlobeNewswire

Oct. 28, 2026

SIGA Secures Contract Valued at Up to $15 Million from Canadian Department of National Defence to Purchase TPOXX®

Indeterminate GlobeNewswire

Oct. 28, 2026

Palvella Announces FDA Acceptance and Priority Review of QTORIN™ Rapamycin NDA; February 28, 2027 PDUFA Target Action Date Set

Indeterminate GlobeNewswire

Oct. 28, 2026

Enovix Declares New Warrant Dividend

Indeterminate GlobeNewswire

Oct. 28, 2026

Micron Biomedical Appoints Anand Subramony, Ph.D., as Executive Vice President, Global Product Development and Combination Product Commercialization

Indeterminate GlobeNewswire

Oct. 28, 2026

7AI Named to Fortune’s 2027 Cyber 60 for Second Consecutive Year

Indeterminate GlobeNewswire

Oct. 28, 2026

Snom expands its partner network with over 500 new partners: strategic meeting in Rome with Platinum and Gold distributors from EMEA and APAC

Indeterminate GlobeNewswire

Oct. 28, 2026

Snom amplía su red con más de 500 nuevos partners: Roma acoge la cumbre estratégica con los distribuidores Platinum y Gold de EMEA y APAC

Indeterminate GlobeNewswire

Oct. 28, 2026

uniQure to Announce Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Oct. 28, 2026

Mineralys Therapeutics Announces Publication of Phase 2 Explore-CKD Trial Results for Lorundrostat in Kidney International

Indeterminate GlobeNewswire

Oct. 28, 2026

Alvotech to Report Financial Results for the Nine-Month Period to September 30, 2026

Indeterminate GlobeNewswire

Oct. 28, 2026

Adagene Announces Dosing of First Patient in Phase 1 Study of Muzastotug in Combination with Incyte’s INCA33890 in Patients with Microsatellite Stable Colorectal Cancer

Indeterminate GlobeNewswire

Oct. 28, 2026

Kashable Report: Inflation Is Changing More Than How Americans Spend. It’s Changing How They See Their Future

Indeterminate GlobeNewswire

Oct. 28, 2026

ADMA Biologics to Report Third Quarter 2026 Financial Results on November 4, 2026

Indeterminate GlobeNewswire

Oct. 28, 2026

Monte Rosa Therapeutics Announces Milestone Achievement Associated with Second Phase 2 Clinical Study Initiation for VAV1-directed Molecular Glue Degrader MRT-6160 (DDY391)

Indeterminate GlobeNewswire

Oct. 28, 2026

NovaBridge Biosciences Appoints Chuck Silberstein as Chief Financial Officer

Indeterminate GlobeNewswire

Oct. 28, 2026

Replimune Reports Fiscal Second Quarter 2027 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire